Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027599
Filing Date
2021-05-13
Accepted
2021-05-13 16:31:36
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rxdx-10q_20210331.htm   iXBRL 10-Q 2612384
2 EX-10.10 rxdx-ex1010_137.htm EX-10.10 1016914
3 EX-31.1 rxdx-ex311_9.htm EX-31.1 20630
4 EX-31.2 rxdx-ex312_8.htm EX-31.2 20604
5 EX-32.1 rxdx-ex321_7.htm EX-32.1 10023
6 EX-32.2 rxdx-ex322_6.htm EX-32.2 10049
  Complete submission text file 0001564590-21-027599.txt   9891643

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20210331.xsd EX-101.SCH 73475
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20210331_cal.xml EX-101.CAL 54693
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20210331_def.xml EX-101.DEF 262359
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20210331_lab.xml EX-101.LAB 520251
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20210331_pre.xml EX-101.PRE 409655
12 EXTRACTED XBRL INSTANCE DOCUMENT rxdx-10q_20210331_htm.xml XML 1243473
Mailing Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121
Business Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121 (858) 200-7888
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

EIN.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40187 | Film No.: 21920134
SIC: 2834 Pharmaceutical Preparations